New biomarkers in pancreatic cancer using EXPEL concept

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will apply a modified EXPEL method during endoscopic ultrasound-guided biopsy or surgery to collect interstitial fluid from pancreatic tissue. The approach aims to enable comprehensive OMICS analyses from the same material used for clinical diagnosis, potentially revealing diagnostic and predictive biomarkers for PDAC. The study is observational and focuses on translating this liquid-biopsy-like collection into actionable biomarker data across disease stages. It leverages bioinformatics and systems biology to integrate multi-omics findings with clinical context. The investigation emphasizes non-destructive sampling to preserve tissue material for concurrent clinical evaluation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with pancreatic mass and suspicion of pancreatic ductal adenocarcinoma requiring endoscopic ultrasound with fine needle biopsy or surgery
* Patient ≥18 years old
* Patient naïve of any treatment of Pancreatic cancer

Exclusion Criteria:

* Patient who reject the study protocol

Where it's running

• Uhmontpellier
  Montpellier, Montpellier, France Recruiting

Study contacts

• Study coordinator: Regis Souche, Md
• Email: fr-souche@chu-montpellier.fr
• Phone: 467337072

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Islet re-transplantation after prior graft failure in adults with type 1 diabetes

  This study looks at whether giving another islet transplant after a prior failed graft helps adults with type 1 diabetes who have severe swings in blood sugar.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07666789

• Tissue models of systemic sclerosis using patient-derived iPSCs

  Researchers will create iPSC lines from people with systemic sclerosis, their healthy relatives, and test them across several cell types to see how the disease affects tissues in the lab.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07650565

• L-dopa treatment for a CTNNB1-related neurodevelopmental disorder in children

  This study tests whether L-dopa can help children with a CTNNB1-related neurodevelopmental disorder who have dystonia.

  Recruiting University Hospital, Montpellier · Montpellier, Hérault · NCT07614126

• Exploratory look at brain blood flow and metabolism before and after removing unruptured AVMs

  This study tests brain perfusion and metabolism with PET imaging and neuropsychological tests in adults before and six months after surgical treatment for unruptured brain AVMs.

  Recruiting University Hospital, Montpellier · Montpellier, France · NCT07569887

• Immun4Cure Cohort of Autoimmune Diseases

  A long-term, 500-person database and biobank is being built to study autoimmune diseases like RA, SLE, and scleroderma, plus healthy adults, using deep profiling and regular follow-ups over five years.

  Recruiting University Hospital, Montpellier · Montpellier · NCT07515638

• Comparing supra-annular versus intra-annular self-expanding aortic valves in routine TAVR practice

  This project will try to see if the supra‑annular Evolut valve or the intra‑annular Navitor valve gives better one‑month procedural success and six‑month clinical and echocardiographic results for patients receiving TAVR with self‑expanding devices.

  Recruiting University Hospital, Montpellier · Montpellier, Occitanie · NCT07506382

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.